On an intention-to-treat basis , with glucose data analyzed regardless of system status , the median percent time in range , from 70-150 mg/dL , was 62 % ( 29 , 87 ) for OCL nights versus 55 % ( 25 , 80 ) for sensor-augmented pump therapy ( P = 0.233 ) .